Sai Life Sciences Limited

Sai Life Sciences Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN L24110TG1999PLC030970 Incorporated 25 January 1999 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹2,192.49 Cr
▲ 29.38% YoY
Computed EBITDA · FY 2026
₹680.29 Cr
▲ 53.76% YoY
Net profit · FY 2026
₹348.91 Cr
▲ 105.08% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹21.23 Cr
Issued & subscribed
Open charges
₹962.36 Cr
Satisfied ₹1,590.09 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
2,995
Latest available

About Sai Life Sciences Limited

Data last updated: 14 July 2026

Sai Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 25 January 1999, the company has been in operation for over 27 years.

Registered with ROC Hyderabad under CIN L24110TG1999PLC030970. Listed.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹21.23 Cr. Formerly known as Sai Dru Syn Laboratories Limited and Sai Advantium Pharma Limited Definitions & Interpretation. It is led by directors including Krishnamraju Kanumuri and Sivaramakrishnan Chittor.

Last AGM: 11 September 2025. Financial statements filed for year ended 31 March 2025. Office: 7 Ikp Knowledge Park, Hyderabad, Telangana.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹2,192.49 Cr, a growth of 29.38% compared to the previous year. The net worth stands at ₹2,483.69 Cr (up 16.7% YoY). Total assets are valued at ₹3,626.14 Cr (up 14.75% YoY).

The company has a workforce of approximately 2,995 employees as per the latest available data.

The company is associated with 1 brand - Sai Life Sciences. As per MCA filings, the company has open charges of ₹962.36 Cr and satisfied charges of ₹1,590.09 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sailife.com.

Company Details of Sai Life Sciences Limited
CIN L24110TG1999PLC030970
Registration Number 030970
Incorporation Date 25 January 1999
ROC Hyderabad
Listing Status Listed
Company Status Active
Date of Last AGM 11 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Krishnamraju Kanumuri Managing Director Sivaramakrishnan Chittor Whole-Time Director Ranga Raju Kanumuri Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    Plot No. Ds – 7 Ikp Knowledge Park Turkapally (V) Shameerpet Mandal Medchal – Malkajgiri Di, St, Hyderabad, Telangana, India – 500078
  • Industry
    Pharma, API Manufacturers, Pharma Contract R&D
Company report
Sai Life Sciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sai Life Sciences Limited report

Financials, compliance, directors, charges, ownership and filings for Sai Life Sciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Sai Life Sciences Limited

Sai Life Sciences Limited has undergone 4 name changes throughout its history. The current legal name is Sai Life Sciences Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Sai Life Sciences Limited Current
Sai Dru Syn Laboratories Limited Previous
Sai Advantium Pharma Limited Definitions & Interpretation Previous
Sai Life Sciences Limited Definitions & Interpretation Previous
Sai Advantium Pharma Limited Previous

CIN History of Sai Life Sciences Limited

Sai Life Sciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24110TG1999PLC030970, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24110TG1999PLC030970 Current
U24110TG1999PLC030970 Previous
U24110AP1999PLC030970 Previous

Associated Brands with Sai Life Sciences Limited

Sai Life Sciences Limited operates one associated brand: Sai Life Sciences. These brands represent Sai Life Sciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Sai Life Sciences
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. sailife.com

Competitors & Alternatives of Sai Life Sciences Limited

Brands and companies operating in the same space as Sai Life Sciences Limited include Acies Bio, Liverpool ChiroChem, IRBM and 5 more.

Competitor Description Location Founded
Acies Bio Acies Bio Provider of drug discovery and development services to pharmaceutical, biotech, and food industries Ljubljana, Slovenia, Slovenia 2006
Liverpool ChiroChem Liverpool ChiroChem Small organic molecules are supplied for biotech and pharmaceutical R&D. Liverpool, United Kingdom, United Kingdom 2014
IRBM IRBM Integrated drug discovery and preclinical development services are provided. Pomezia, Italy, Italy 2010
New Iridium New Iridium Phenoxazine and dihydrophenazine are manufactured by New Iridium. Boulder, United States, United States 2016
NFIL NFIL Fluorinated compounds are synthesized and manufactured customly for various industries. Mumbai, India, India 1967
Personal Chemistry Personal Chemistry Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. Uppsala, Sweden, Sweden 1998
Automera Automera Autophagy-driven degradation is pioneered through computational chemistry and AI. Singapore, Singapore, Singapore 2022
SpiroChem SpiroChem Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry Zurich, Switzerland, Switzerland 2011

Business Activity of Sai Life Sciences Limited

Sai Life Sciences Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Sai Life Sciences Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Sai Life Sciences Limited

Sai Life Sciences Limited is audited by Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
Deloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Sai Life Sciences Limited

Sai Life Sciences Limited is currently managed by 6 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Krishnamraju Kanumuri
Also directs: Sai Life Sciences Limited, Sai Life Pharma Private Limited, South India Research Institute Pvt Ltd
Managing Director 01 Oct 2010 15 Years 10 Months Current
Sivaramakrishnan Chittor
Also directs: Sai Life Sciences Limited
Whole-Time Director 28 Apr 2025 1 Years 3 Months Current
Ranga Raju Kanumuri
Also directs: Jrv Properties Llp, Sai Life Sciences Limited, Sai Quest Syn Private Limited and 3 more
Whole-Time Director 25 Jan 1999 27 Years 6 Months Current
Suchita Sharma
Also directs: Sai Life Sciences Limited, Roppen Transportation Services Private Limited
Director 10 Jun 2024 2 Years 2 Months Current
Ramesh Ganesh Iyer
Also directs: Sai Life Sciences Limited, Kotak Mahindra Bank Limited, Nocil Limited and 4 more
Director 21 May 2024 2 Years 2 Months Current
Dinesh V Patel
Also directs: Sai Life Sciences Limited
Director 24 Mar 2025 1 Years 4 Months Current
View all directors

Financials of Sai Life Sciences Limited FY 2026 filings available

Sai Life Sciences Limited reported revenue of ₹2,192.49 Cr (up 29.38% YoY) for FY 2026.

Revenue · FY 2026
₹2,192.49 Cr ▲ 29.38%
Profit · FY 2026
₹348.91 Cr ▲ 105.08%
Computed EBITDA · FY 2026
₹680.29 Cr ▲ 53.76%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2025: ₹1,695 Cr1,695FY 2025FY 2026: ₹2,192 Cr · +29.4% YoY2,192+29.4%FY 2026
Net Profit₹ Cr · Consolidated0200400FY 2025: ₹170 Cr170FY 2025FY 2026: ₹349 Cr · +105.1% YoY349+105.1%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0250500750Q3'25: ₹440 Cr440Q3'25Q4'25: ₹580 Cr580Q4'25Q1'26: ₹496 Cr496Q1'26Q2'26: ₹537 Cr537Q2'26Q3'26: ₹556 Cr · +26.5% YoY556+26.5%Q3'26Q4'26: ₹602 Cr · +3.9% YoY602+3.9%Q4'26
Metrics FY 2026 FY 2025
Revenue from Operations ₹2,192.49 Cr ₹1,694.57 Cr
Other Income ₹49.13 Cr ₹36.78 Cr
Total Income ₹2,241.62 Cr ₹1,731.35 Cr
Cost of Materials Consumed ₹578.12 Cr ₹460.8 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories -₹7.22 Cr ₹4.97 Cr
Employee Benefit Expense ₹683.06 Cr ₹549.12 Cr
Finance Costs ₹39.24 Cr ₹76.16 Cr
Depreciation & Amortisation ₹166.86 Cr ₹138.57 Cr
Other Expenses ₹307.39 Cr ₹274.03 Cr
Total Expenses ₹1,767.43 Cr ₹1,503.65 Cr
Profit Before Exceptional Items & Tax ₹474.19 Cr ₹227.7 Cr
Exceptional Items -₹8 Cr ₹0
Profit Before Tax ₹466.19 Cr ₹227.7 Cr
Total Tax Expense ₹117.28 Cr ₹57.57 Cr
Net Profit ₹348.91 Cr ₹170.13 Cr
Other Comprehensive Income -₹20.82 Cr ₹1.19 Cr
Total Comprehensive Income ₹328.09 Cr ₹171.32 Cr
EBITDA (computed) ₹680.29 Cr ₹442.44 Cr
Basic EPS ₹16.63 ₹8.83
Diluted EPS ₹16.43 ₹8.61
Metrics FY 2026 FY 2025
Total Assets ₹3,626.14 Cr ₹3,159.98 Cr
Non-current Assets ₹2,215.61 Cr ₹1,655.46 Cr
Current Assets ₹1,410.53 Cr ₹1,504.51 Cr
Property, Plant & Equipment ₹1,808.72 Cr ₹1,477.36 Cr
Inventories ₹150.97 Cr ₹118.87 Cr
Trade Receivables ₹373.62 Cr ₹354.78 Cr
Cash & Equivalents ₹81.91 Cr ₹91.12 Cr
Equity (Net Worth) ₹2,483.69 Cr ₹2,128.35 Cr
Equity Share Capital ₹21.18 Cr ₹20.84 Cr
Borrowings (Non-current) ₹20.5 Cr ₹0
Borrowings (Current) ₹74.62 Cr ₹128.64 Cr
Total Debt (computed) ₹95.13 Cr ₹128.64 Cr
Current Liabilities ₹833.68 Cr ₹732.49 Cr
Total Liabilities ₹1,142.45 Cr ₹1,031.62 Cr
Metrics FY 2026 FY 2025
Operating Cash Flow ₹509.13 Cr ₹314.05 Cr
Investing Cash Flow -₹395.41 Cr -₹536.67 Cr
Financing Cash Flow -₹123.68 Cr ₹301.43 Cr
Capital Expenditure ₹592.96 Cr ₹369.28 Cr
Free Cash Flow (computed) -₹83.83 Cr -₹55.24 Cr
Dividends Paid ₹0 ₹0
Net Change in Cash -₹9.14 Cr ₹79.08 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25
Revenue from Operations ₹602.14 Cr ₹556.46 Cr ₹537.47 Cr ₹496.42 Cr ₹579.51 Cr ₹439.78 Cr
Other Income ₹15.52 Cr ₹8.38 Cr ₹15.33 Cr ₹9.9 Cr ₹9.6 Cr ₹9.12 Cr
Total Income ₹617.66 Cr ₹564.84 Cr ₹552.8 Cr ₹506.32 Cr ₹589.11 Cr ₹448.89 Cr
Cost of Materials Consumed ₹159.19 Cr ₹114.24 Cr ₹203.53 Cr ₹159.5 Cr ₹156.87 Cr ₹121.53 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹2.52 Cr ₹13.71 Cr -₹63.41 Cr -₹18.39 Cr ₹10.85 Cr -₹70.1 Lakh
Employee Benefit Expense ₹186.65 Cr ₹172.99 Cr ₹162.79 Cr ₹160.62 Cr ₹151.09 Cr ₹132.94 Cr
Finance Costs ₹7.83 Cr ₹9.7 Cr ₹9.35 Cr ₹12.36 Cr ₹10.89 Cr ₹23.13 Cr
Depreciation & Amortisation ₹45.31 Cr ₹44.08 Cr ₹39.75 Cr ₹37.72 Cr ₹37.49 Cr ₹34.09 Cr
Other Expenses ₹77.23 Cr ₹67.67 Cr ₹88.73 Cr ₹73.76 Cr ₹103.12 Cr ₹66.26 Cr
Total Expenses ₹478.72 Cr ₹422.39 Cr ₹440.74 Cr ₹425.58 Cr ₹470.31 Cr ₹377.25 Cr
Profit Before Exceptional Items & Tax ₹138.94 Cr ₹142.46 Cr ₹112.05 Cr ₹80.75 Cr ₹118.8 Cr ₹71.65 Cr
Exceptional Items ₹29.2 Lakh -₹8.29 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹139.23 Cr ₹134.17 Cr ₹112.05 Cr ₹80.75 Cr ₹118.8 Cr ₹71.65 Cr
Total Tax Expense ₹34.99 Cr ₹33.79 Cr ₹28.21 Cr ₹20.29 Cr ₹30.53 Cr ₹17.8 Cr
Net Profit ₹104.24 Cr ₹100.38 Cr ₹83.84 Cr ₹60.46 Cr ₹88.27 Cr ₹53.85 Cr
  attributable to Owners - ₹0 ₹0 - - ₹0
  attributable to NCI - ₹0 ₹0 - - ₹0
Other Comprehensive Income -₹9.11 Cr ₹91.1 Lakh -₹14.23 Cr ₹1.62 Cr ₹7.34 Cr -₹3.9 Cr
Total Comprehensive Income ₹95.12 Cr ₹101.29 Cr ₹69.61 Cr ₹62.07 Cr ₹95.61 Cr ₹49.96 Cr
EBITDA (computed) ₹192.07 Cr ₹196.23 Cr ₹161.15 Cr ₹130.84 Cr ₹167.17 Cr ₹128.87 Cr
Basic EPS ₹4.93 ₹4.77 ₹4.01 ₹2.90 ₹4.24 ₹2.89
Diluted EPS ₹4.87 ₹4.71 ₹3.93 ₹2.83 ₹4.14 ₹2.84
Latest 6 quarters shown.
Metrics FY 2026 FY 2025
Revenue from Operations ₹2,153.23 Cr ₹1,642.05 Cr
Other Income ₹49.13 Cr ₹37.34 Cr
Total Income ₹2,202.36 Cr ₹1,679.38 Cr
Cost of Materials Consumed ₹568.34 Cr ₹445.52 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories -₹7.76 Cr ₹4.13 Cr
Employee Benefit Expense ₹617.73 Cr ₹485.56 Cr
Finance Costs ₹32.62 Cr ₹70.03 Cr
Depreciation & Amortisation ₹152.3 Cr ₹126.03 Cr
Other Expenses ₹374.96 Cr ₹316.4 Cr
Total Expenses ₹1,738.18 Cr ₹1,447.67 Cr
Profit Before Exceptional Items & Tax ₹464.17 Cr ₹231.72 Cr
Exceptional Items -₹8 Cr ₹0
Profit Before Tax ₹456.17 Cr ₹231.72 Cr
Total Tax Expense ₹114.69 Cr ₹58.25 Cr
Net Profit ₹341.48 Cr ₹173.46 Cr
Other Comprehensive Income -₹28.22 Cr ₹91.5 Lakh
Total Comprehensive Income ₹313.26 Cr ₹174.38 Cr
EBITDA (computed) ₹649.09 Cr ₹427.78 Cr
Basic EPS ₹16.27 ₹9.00
Diluted EPS ₹16.08 ₹8.78
Metrics FY 2026 FY 2025
Total Assets ₹3,602.82 Cr ₹3,136.66 Cr
Non-current Assets ₹2,203.69 Cr ₹1,642.12 Cr
Current Assets ₹1,399.13 Cr ₹1,494.54 Cr
Property, Plant & Equipment ₹1,698.61 Cr ₹1,367.04 Cr
Inventories ₹149.9 Cr ₹118.33 Cr
Trade Receivables ₹369.71 Cr ₹352.87 Cr
Cash & Equivalents ₹78.6 Cr ₹85.19 Cr
Equity (Net Worth) ₹2,507.97 Cr ₹2,167.46 Cr
Equity Share Capital ₹21.18 Cr ₹20.84 Cr
Borrowings (Non-current) ₹20.5 Cr ₹0
Borrowings (Current) ₹74.62 Cr ₹128.64 Cr
Total Debt (computed) ₹95.13 Cr ₹128.64 Cr
Current Liabilities ₹842.26 Cr ₹727.2 Cr
Total Liabilities ₹1,094.85 Cr ₹969.2 Cr
Metrics FY 2026 FY 2025
Operating Cash Flow ₹495.27 Cr ₹330.35 Cr
Investing Cash Flow -₹392.71 Cr -₹564.71 Cr
Financing Cash Flow -₹109.23 Cr ₹314.31 Cr
Capital Expenditure ₹590.26 Cr ₹363.49 Cr
Free Cash Flow (computed) -₹94.99 Cr -₹33.14 Cr
Dividends Paid ₹0 ₹0
Net Change in Cash -₹6.52 Cr ₹79.95 Cr
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25
Revenue from Operations ₹594.34 Cr ₹549.18 Cr ₹526.67 Cr ₹483.04 Cr ₹567.01 Cr ₹428.6 Cr
Other Income ₹15.75 Cr ₹8.45 Cr ₹14.93 Cr ₹10.01 Cr ₹9.82 Cr ₹9.45 Cr
Total Income ₹610.09 Cr ₹557.63 Cr ₹541.6 Cr ₹493.04 Cr ₹576.83 Cr ₹438.05 Cr
Cost of Materials Consumed ₹158.48 Cr ₹112.76 Cr ₹141.78 Cr ₹155.33 Cr ₹154.06 Cr ₹116.92 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹1.99 Cr ₹13.78 Cr -₹5.37 Cr -₹18.15 Cr ₹10.33 Cr -₹25.5 Lakh
Employee Benefit Expense ₹169.88 Cr ₹159.23 Cr ₹146.04 Cr ₹142.59 Cr ₹134.55 Cr ₹121.06 Cr
Finance Costs ₹6.16 Cr ₹8.06 Cr ₹7.7 Cr ₹10.7 Cr ₹9.16 Cr ₹21.66 Cr
Depreciation & Amortisation ₹41.16 Cr ₹40.6 Cr ₹36.21 Cr ₹34.33 Cr ₹34.1 Cr ₹31.07 Cr
Other Expenses ₹95.85 Cr ₹84.45 Cr ₹104.38 Cr ₹90.27 Cr ₹114.16 Cr ₹79.69 Cr
Total Expenses ₹473.53 Cr ₹418.86 Cr ₹430.73 Cr ₹415.06 Cr ₹456.36 Cr ₹370.14 Cr
Profit Before Exceptional Items & Tax ₹136.56 Cr ₹138.76 Cr ₹110.87 Cr ₹77.98 Cr ₹120.47 Cr ₹67.91 Cr
Exceptional Items ₹29.2 Lakh -₹8.29 Cr ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹136.85 Cr ₹130.47 Cr ₹110.87 Cr ₹77.98 Cr ₹120.47 Cr ₹67.91 Cr
Total Tax Expense ₹34.32 Cr ₹32.84 Cr ₹27.92 Cr ₹19.61 Cr ₹30.53 Cr ₹16.86 Cr
Net Profit ₹102.53 Cr ₹97.63 Cr ₹82.95 Cr ₹58.37 Cr ₹89.94 Cr ₹51.06 Cr
Other Comprehensive Income -₹13.15 Cr ₹8.8 Lakh -₹16.65 Cr ₹1.49 Cr ₹7.31 Cr -₹5.14 Cr
Total Comprehensive Income ₹89.38 Cr ₹97.72 Cr ₹66.3 Cr ₹59.86 Cr ₹97.24 Cr ₹45.92 Cr
EBITDA (computed) ₹183.89 Cr ₹187.42 Cr ₹154.78 Cr ₹123 Cr ₹163.72 Cr ₹120.64 Cr
Basic EPS ₹4.85 ₹4.64 ₹3.97 ₹2.80 ₹4.32 ₹2.74
Diluted EPS ₹4.79 ₹4.58 ₹3.89 ₹2.73 ₹4.22 ₹2.69
Latest 6 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Sai Life Sciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Board & Governance of Sai Life Sciences Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Sai Life Sciences Limited has 6 directors - 3 independent and 3 executive. The board is chaired by Ranga Raju Kanumuri.

DirectorPositionOn board sinceListed boards
Ranga Raju Kanumuri Executive Director · Chairperson 1999-01-25 1
Kanumuri Krishnam Raju Executive Director 2010-10-01 1
Ramesh Ganesh Iyer Non-Executive - Independent Director 2024-05-21 3
Dinesh V Patel Non-Executive - Independent Director 2025-03-24 1
Suchita Sharma Non-Executive - Independent Director 2024-06-10 1
Sivaramakrishnan Chittor Executive Director 2025-04-28 1
Board Committees
CommitteeMembers
Audit Committee Suchita Sharma (Chairperson), Dinesh V Patel, Ramesh Ganesh Iyer
Nomination and remuneration committee Ramesh Ganesh Iyer (Chairperson), Dinesh V Patel, Suchita Sharma
Stakeholders Relationship Committee Ramesh Ganesh Iyer (Chairperson), Kanumuri Krishnam Raju, Suchita Sharma
Risk Management Committee Ramesh Ganesh Iyer (Chairperson), Kanumuri Krishnam Raju, Sivaramakrishnan Chittor
Corporate Social Responsibility Committee Suchita Sharma (Chairperson), Ramesh Ganesh Iyer, Kanumuri Krishnam Raju, Dinesh V Patel, Sivaramakrishnan Chittor

Charges & Borrowings of Sai Life Sciences Limited

Open charges
₹962.36 Cr
Satisfied charges
₹1,590.09 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹912.36 Cr
Axis Bank Limited₹50.00 Cr
Latest charge details
DateLenderAmountStatus
13 Mar 2026 Axis Bank Limited ₹50 Cr Open
06 Oct 2023 Sbicap Trustee Company Limited ₹768.6 Cr Open
06 Oct 2023 Sbicap Trustee Company Limited ₹25 Cr Open
06 Oct 2023 Sbicap Trustee Company Limited ₹18.76 Cr Open
06 Oct 2023 Sbicap Trustee Company Limited ₹100 Cr Open

Total charge records: 38 View all charges

Employees and EPFO Compliance at Sai Life Sciences Limited

View historical data on people associated with Sai Life Sciences Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Sai Life Sciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sai Life Sciences Limited

Premium access

GST registrations and filing compliance for Sai Life Sciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sai Life Sciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sai Life Sciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sai Life Sciences Limited

Premium access

MSME payment history for Sai Life Sciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sai Life Sciences Limited

Premium access

Corporate group structure for Sai Life Sciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sai Life Sciences Limited

Premium access

MCA filings and documents for Sai Life Sciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sai Life Sciences Limited

Charges
13 Mar 2026
A charge with Axis Bank Limited amounted to Rs. 50.00 Cr with Charge ID 101268280 was registered on 13 Mar 2026.
Activity
11 Sep 2025
Sai Life Sciences Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records.
Directors
16 May 2025
Sivaramakrishnan Chittor was appointed as a Cfo on 16 May 2025 & has been associated with this company since 1 year 2 months.
Directors
28 Apr 2025
Sivaramakrishnan Chittor was appointed as a Whole-time director on 28 Apr 2025 & has been associated with this company since 1 year 3 months.
Activity
31 Mar 2025
Sai Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
26 Mar 2025
A charge registered on 06 Oct 2023 via Charge ID 100817152 with Sbicap Trustee Company Limited was fully satisfied on 26 Mar 2025.

Recent News on Sai Life Sciences Limited

Investors flock to IPOs amid secondary market volatility
26 Jan 2025 · Thehindubusinessline

Frequently Asked Questions about Sai Life Sciences Limited

Sai Life Sciences Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 25 January 1999 (27+ years old) and is registered under CIN L24110TG1999PLC030970. The company has 2,995 employees.

Sai Life Sciences Limited reported revenue of ₹2,192.49 Cr for FY 2026 (up 29.38% YoY) based on consolidated NSE filings.

The current directors of Sai Life Sciences Limited are:

The primary industry of Sai Life Sciences Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes, Sai Life Sciences Limited is a listed company.

Sai Life Sciences Limited can be reached at the registered office: Plot No. Ds – 7 Ikp Knowledge Park Turkapally V Shameerpet Mandal Medchal – Malkajgiri Di, St, Hyderabad, Telangana, India – 500078, or through the website sailife.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available